Revosimeline is a muscarinic acetylcholine receptor agonist which has not been marketed at this time. It is said to be an agonist of the muscarinic acetylcholine M1 receptor. The drug appears to be structurally distinct from earlier muscarinic acetylcholine receptor agonists like milameline and xanomeline. Its INNTooltip International Nonproprietary Name was designated in 2018.
References